4 June, 2026
In an unprecedented show of unity, the European Respiratory Society (ERS), alongside a coalition of nearly 500 organizations, researchers, and patient advocacy groups, has issued an urgent ultimatum to European Union leadership. As negotiations regarding the next Multiannual Financial Framework (MFF)—the EU’s long-term budget—reach a critical impasse, the health community is demanding that public health be formalised as a primary strategic pillar of the Union, supported by a dedicated, ringfenced budget.
This coordinated action represents one of the largest advocacy efforts in the history of the European health sector, signaling a growing anxiety that without systemic financial reform, the EU’s vision of a competitive, resilient, and secure economy will be undermined by a preventable public health crisis.
The Core Mandate: Why Health is the Foundation of Competitiveness
The central argument presented to European Commission President Ursula von der Leyen and European Council President António Costa is as straightforward as it is profound: a competitive economy cannot be sustained by a sickly population.
For too long, public health funding has been treated as a discretionary expenditure rather than an essential infrastructure investment. As the EU navigates a complex geopolitical landscape defined by economic insecurity and the need for internal resilience, the coalition argues that health has begun to "slip down the political agenda."
The signatories of the joint letter contend that the EU’s current focus on competitiveness and economic security is incomplete if it fails to address the foundational workforce health that enables such progress. By ringfencing a specific portion of the MFF for health, the coalition aims to move beyond the reactive "crisis-mode" spending that characterized the post-COVID-19 era and toward a sustainable, proactive strategy of prevention and long-term care.
Chronology: A Multi-Year Battle for Prioritisation
The path to this moment has been paved with years of systemic challenges and shifting political tides.
- 2020–2022 (The Pandemic Catalyst): The COVID-19 pandemic exposed the fragility of European health systems. The subsequent rollout of the EU4Health program provided a temporary, albeit insufficient, injection of capital to bolster resilience.
- 2024 (Rising Awareness): As the dust settled on the pandemic, European health organizations began documenting the "hidden" economic toll of non-communicable diseases (NCDs), such as respiratory illnesses, cardiovascular disease, and cancer.
- Spring 2026 (Parliamentary Alignment): The European Parliament reached a milestone in its negotiations for the next MFF, formally proposing a €10 billion investment specifically for health. This move provided the political momentum needed for the current coalition to launch their unified appeal.
- June 2026 (The Current Stand): The letter from the 500-organization coalition marks the transition from parliamentary debate to the high-stakes negotiations within the European Council, where the individual interests of Member States will dictate the final budget structure.
The Economic Burden: The Cost of Inaction
The economic rationale for this investment is supported by staggering data from the World Health Organization (WHO). According to their most recent assessments, Europe sustains a loss of approximately €442 billion in productivity annually due to premature deaths and morbidity linked exclusively to non-communicable diseases.
This figure is not merely a statistical abstraction; it represents a profound drain on the EU’s GDP. When citizens suffer from preventable respiratory diseases or chronic health conditions, the impact ripples across the entire economic ecosystem:
- Labor Participation: Reduced workforce participation among the aging population.
- Healthcare Overload: Increased pressure on national health systems, diverting funds from innovation to emergency maintenance.
- Innovation Stagnation: A population burdened by chronic illness is less capable of contributing to the rapid technological and digital transitions the EU has identified as its strategic goals.
The coalition argues that the current "cost of inaction" far exceeds the proposed €10 billion investment. They posit that the next MFF must reflect a long-term fiscal view: spending on prevention today will yield compounding returns in economic productivity and social stability for decades to come.
Official Perspectives and Expert Advocacy
The advocacy campaign is spearheaded by high-profile figures who argue that health is not a matter of charity, but a matter of human rights and security.
Prof. Barbara Hoffmann, Chair of the ERS Advocacy Council, has been a vocal proponent of this paradigm shift. In her official statement, she noted:
"Health is not a luxury—it is a human right. It is paramount that the importance of health is recognised as a priority area in the next MFF, with its own ringfenced budget allocated. Without this, Europe’s future is at risk, given the public health and economic implications of a failure to act. Spending for health and prevention may seem significant now, but the cost of inaction will be much higher in the future. I urge EU leaders and Member States to take this opportunity to play their part in protecting the future health of European citizens."
The coalition also highlights the disparate responses from Member States. While several nations have voiced support for a health-focused budget, others remain hesitant, prioritizing traditional sectors like agriculture, defense, or infrastructure. The coalition’s goal is to convince these hesitant states that their own national interests are best served by a robust, EU-wide health strategy.
Implications: The Road Ahead for the EU Council
The success of this movement now hinges on the deliberations of the European Council. The MFF negotiation process is notoriously complex, requiring unanimity among Member States, which often leads to the dilution of specialized budget lines in favor of broad, compromise-heavy agreements.
1. The Risk of Fragmentation
If the Council chooses not to ringfence health funding, the result will likely be a fragmented landscape where wealthier Member States can afford advanced health infrastructure, while others fall behind. This gap would undermine the EU’s goal of social and territorial cohesion, leading to a "two-tier" health reality within the bloc.
2. Strategic Autonomy and Public Health
In the context of "strategic autonomy"—the EU’s push to become less dependent on external powers—health must be viewed as a pillar of sovereignty. Dependence on external suppliers for medicines, diagnostic tools, and vaccines has proven dangerous. A dedicated budget would allow for the centralization of research, the creation of a robust European health supply chain, and the rapid deployment of medical resources.
3. The Future of European Policy
The outcome of the MFF negotiations will set the tone for the next decade of European policy. If the EU integrates health into its core economic strategy, it will be a landmark moment for the bloc’s identity. If it fails to do so, the health community warns that the Union may find itself addressing symptoms rather than causes, perpetually playing catch-up to the next demographic or public health crisis.
Conclusion: A Turning Point for European Citizens
As negotiations intensify through the latter half of 2026, the joint call from the ERS and its partners serves as a stark reminder of the stakes. The European health community has done its part to illuminate the path forward, providing the data, the moral imperative, and the political consensus required to act.
The €10 billion proposal from the European Parliament is a start, but it remains a proposal until it is enshrined in the final budget. For European citizens, the decision will determine the quality of life, the resilience of their healthcare systems, and the long-term stability of the European project itself.
As Prof. Hoffmann aptly summarized, the cost of inaction is a burden that the continent cannot afford to bear. The European Council now holds the mandate to choose: to view health as an essential foundation for a prosperous, competitive, and human-centric Union, or to leave the continent vulnerable to the preventable costs of the past.
Further Reading and Resources:
